Gong Jin-Ying, Zhang Zhen-Hao, Zhang Wei, Wang Hui-Jun, Feng Xiao-Fang, Zhou Ji, Zhu Guo-Qing
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 288 Nanjing Road, Heping District, Tianjin, 300020 People's Republic of China.
Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191 People's Republic of China.
Mol Cytogenet. 2020 Aug 19;13:34. doi: 10.1186/s13039-020-00501-6. eCollection 2020.
Progression of chronic myelogenous leukemia (CML) is frequently accompanied by cytogenetic evolution. Additional genetic abnormalities are seen in 10-20% of CML cases at the time of diagnosis, and in 60-80% of cases of advanced disease. Unbalanced chromosomal changes such as an extra copy of the Philadelphia chromosome (Ph), trisomy 8, and i(17)(q10) are common. Balanced chromosomal translocations, such as t(3;3), t(8;21), t(15;17), and inv(16) are typically found in acute myeloid leukemia, but rarely occur in CML. Translocations involving 11q23, t(8;21), and inv(16) are relatively common genetic abnormalities in acute leukemia, but are extremely rare in CML. In the literature to date, there are at least 76 Ph+ cases with t(3;21), 47 Ph+ cases with inv(16), 16 Ph+ cases with t(8;21), and 9 Ph+ cases with t(9;11). But most of what has been published is now over 30 years old, without the benefit of modern immunophenotyping to confirm diagnosis, and before the introduction of treatment regimes such as TKI. In this study, we explored the rare concomitant occurrence of coexistence current chromosomal translocation and t(9;22) in CML or acute myeloid leukemia (AML).
慢性粒细胞白血病(CML)的进展常伴有细胞遗传学演变。在10%-20%的CML病例诊断时可发现额外的基因异常,而在60%-80%的晚期疾病病例中可发现。染色体不平衡改变如额外的费城染色体(Ph)拷贝、8号染色体三体和i(17)(q10)很常见。平衡染色体易位,如t(3;3)、t(8;21)、t(15;17)和inv(16)通常见于急性髓系白血病,但在CML中很少发生。涉及11q23、t(8;21)和inv(16)的易位在急性白血病中是相对常见的基因异常,但在CML中极为罕见。在迄今为止的文献中,至少有76例Ph+病例伴有t(3;21),47例Ph+病例伴有inv(16),16例Ph+病例伴有t(8;21),9例Ph+病例伴有t(9;11)。但已发表的大多数内容距今已有30多年,没有现代免疫表型分析来确诊,且是在引入TKI等治疗方案之前。在本研究中,我们探讨了CML或急性髓系白血病(AML)中罕见的同时存在的当前染色体易位和t(9;22)共存情况。